Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127840151 | 12784015 | 1 | I | 2016 | 20160922 | 20160927 | 20160927 | EXP | CN-GLAXOSMITHKLINE-CN2016GSK139523 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160927 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127840151 | 12784015 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 21077 | INHALATION POWDER | ||||||||||
| 127840151 | 12784015 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | 21077 | INHALATION POWDER |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127840151 | 12784015 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127840151 | 12784015 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127840151 | 12784015 | Drug dependence | |
| 127840151 | 12784015 | Drug ineffective | |
| 127840151 | 12784015 | Intentional product misuse | |
| 127840151 | 12784015 | Product quality issue | |
| 127840151 | 12784015 | Therapeutic response unexpected | |
| 127840151 | 12784015 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |